
Proteomic signatures of APOE ε4 and APOE ε2 genetic variants and Alzheimer's dis
The APOE gene is the strongest genetic factor for Alzheimer's disease, with the ε4 variant increasing risk and ε2 decreasing it, but the molecular mechanisms behind these opposing effects are not fully understood. A multicohort proteomic analysis across plasma and cerebrospinal fluid revealed distinct molecular pathways associated with each variant, detectable before amyloid pathology and stable across disease stages. APOE2 is linked to cellular maintenance and anti-inflammatory processes, while APOE4 is associated with cell-cycle dysregulation, vascular dysfunction, and downstream pathological changes.
- ▪APOE ε4 increases Alzheimer's disease risk in a dose-dependent manner, while APOE ε2 reduces it.
- ▪Proteomic changes linked to APOE variants are detectable before amyloid pathology and remain stable across aging and disease progression.
- ▪APOE2-associated proteins are enriched in cellular maintenance and anti-inflammatory pathways, whereas APOE4 is linked to cell-cycle dysregulation and downstream vascular, immune, and proteostatic dysfunction.
- ▪The study analyzed data from multiple cohorts including GNPC, BioFINDER-2, ADNI, UK Biobank, and PPMI, enhancing generalizability.
- ▪Distinct molecular architectures underlying APOE2 and APOE4 suggest potential targets for allele-specific interventions in Alzheimer's disease.
Hacker News (Newest) files mainly under programming. We currently carry 5,306 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | Nature |
| Canonical URL | https://www.nature.com/articles/s43587-026-01123-0 |
| Publication time | Sat, 16 May 2026 15:27:47 +0000 |
| Retrieval time | 2026-05-16T15:40:18.968Z |
| Last seen | 2026-05-16T15:40:28.530Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | rAfxD-NDDBaw |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
Download PDF Article Open access Published: 15 May 2026 Proteomic signatures of the APOE ε4 and APOE ε2 genetic variants and Alzheimer’s disease Lina Lu ORCID: orcid.org/0000-0001-9395-242X1, Alexa Pichet Binette1,2,3, Ines Hristovska1, Shorena Janelidze ORCID: orcid.org/0000-0003-2869-83781, Bart Smets4, Irene Cumplido-Mayoral1, Aparna Vasanthakumar5, Britney Milkovich5, The Global Neurodegeneration Proteomics Consortium (GNPC), Lijun An ORCID: orcid.org/0000-0003-1030-46256, Rik Ossenkoppele1,7,8, Varsha Krish9, Farhad Imam ORCID: orcid.org/0000-0003-2854-25689, Sebastian Palmqvist ORCID: orcid.org/0000-0002-9267-19301,10, Jacob W.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Nature.